immunological emergencies in paramedic practice Flashcards
Thunderstorm Asthma Key Facts:
21 November 2016
• 1358: 35⁰c, BoM issues severe weather warning (thunderstorms, winds, hail) for Western Victoria
• No evidence to suggest severe asthma likely
• Onset 1700 - 1800 in West of Melbourne
• 1900-1915: 201 emergency ambulance requests
• 2000: 100 Code 1 responses pending dispatch
• Highest ever ambulance demand
• Police and fire brigade enlisted to respond to medical emergencies
Ambulance managers used in response capacity
• Hospitals running out of salbutamol
• Ambulance responding code 1 to branches for oxygen
• 10 patients subsequently died
• Majority of MICA requests not fulfilled
Asthma History taking:
• Questioning o Time of onset o Severity compared to other episodes o Medication regime (relief?) o Prodrome o PHx ICU / ETT o Recent ED / ambulance attendance
• Assessments o Full clinical approach o 12L ECG o SpO 2 – unreliable indicator of severity o Conscious EtCO2 monitoring? •Differential diagnosis o Anaphylaxis o AECOPD o APO o Bronchiolitis o UAO
Acute Asthma Management:
Mild or moderate exacerbation
o pMDI
salbutamol
Severe exacerbation
o Nebulised salbutamol and ipratropium
o Oral / IV corticosteroid (prednisolone / hydrocortisone / dexamethasone)
o IM adrenaline if unimproved / worsening
Critical exacerbation
– above Mx plus
o Consider need for APPV
– slow ventilations, long expiratory time
o IV adrenaline (infusion if available, low dose)
o IV magnesium, IV aminophylline (bronchodilators)
o NIV – CPAP /
BiPAP (controversial, scarcely available prehospital)
o Consider DFI –ketamine (bronchodilator) + paralytic
o Mechanical ventilation w/ I:E ratio 1:3 -5 (normal 1:2)
o Chest decompression
Asthma management - Pharm:
- Salbutamol pharmacology:
β2 adrenergic agent that causes smooth muscle relaxation = bronchodilation
Asthma management - Pharm:
- Ipratropium
Anticholinergic agent that blocks
bronchoconstricting
- causing parasympathetic ANS tone and allow increases bronchodilating
- causing sympathetic tone to maximise
o Acts synergistically with salbutam
Asthma management - Pharm:
- Corticosteroids (prednisolone/ hydrocortisone/dexamethasone etc)
o Inhibit inflammatory response
o Benefits over longer term, hospital duration, representation
etc
Asthma management - pharm:
- Ketamine
o NMDA receptor antagonist that causes dissociation
o Sympathomimetic that causes some degree of bronchodilation
o Preferred agent for DFI of asthmatic patient
Asthma management - pharm:
- Adrenaline
o α1 effects cause vasoconstriction to overcome raised intrathoracic pressure and
increase preload
o β2 adrenergic effects cause bronchodilation
o β2 effects mediate degranulation of mast cells and histamine release
RASH criteria - Anaphylaxis:
sudeen onset of symptoms (minutes to hours)
AND
two or more of RASH with or without comfirmed antigen exposure.
- R = respiratory distress (SOB, Wheeze, cough, stridor)
- A = Abdominal symptoms (nausea, vomiting, abdo pain/cramps + diarrhoea)
- S = skin/mucosal symptoms
(hives, itch flushing, swollen lips/tongue) - H = Hypotension (or altered conscious state)
OR - isolated hypotension (SBP < 90) following exposure to known antigen)
Anaphylaxis management:
-
- Early identification of possible anaphylaxis
- IM adrenaline as first line agent regardless of severity
- Do not stand the patient (next slide)
- High flow oxygen (why?)
- Once IM adrenaline given and established, consider life threatening problems
o Hypotension: normal saline fluid resuscitation
o Bronchospasm: salbutamol +/- ipratropium
o Airway angioedema: nebulised adrenaline - IV access for all presentations
- Intensive care backup for sick patients / non-responsive to adrenaline
o Glucagon if β -blocked and non responsive to adrenaline
o IV adrenaline therapy, IVI preferred - Transport for all patients regardless of resolution
o Biphasic anaphylaxis (4 hour observation period minimal)
o Protracted anaphylaxis - Steroids no longer indicated
Sepsis:
- systemic inflammatory disorder
- Mostly bacterial sources
- major morbidity and mortality (higher than storke and AMI)
- At risk groups
o Immunosuppressed
o Elderly
o Children - Difficult to screen for
o No prehospital validated scoring systems
o Difficult in hospital
SIRS
SEPSIS
SEVERE SEPSIS
SEPTIC SHOCK
SIRS criteria: as above (BP substituted for WCC in hospital)
Sepsis = SIRS criteria + actual or suspected infection
Severe sepsis = sepsis + organ dysfunction
Septic shock = sepsis + hypotension refractory to fluid administration
Sepsis management:
- Recognition
• Largest mortality benefit likely recognition in less unwell patients - Transport
• Appropriate destination for sick patients (ICU / HDU)
• Appropriate action plan with safety netting for less sick patients - Oxygen therapy
• Target SpO2 >93% for most patients
• High flow O2 for septic shock - Fluid administration for poor perfusion
• Renal protective
• Problems and risks specific to sepsis? - Inotropic / vasopressor therapy
• Adrenaline or noradrenaline IV infusion
• Limited to ICPs
• High doses possibly needed – side effects? - Intubation
• Risky due to pathophysiological processes
• Limited to ICPs –reluctant procedure
Febrile Neutropenia management:
Any febrile chemotherapy patient • Immediate emergency transport • Manage for sepsis symptomatically • Consider aseptic techniques • Destination may require consult